medline.ch Onkologie Urologische Tumoren

	Three-dimensional image guidance using instrument tracking facilitates intraoperative resection-line determination during robot-assisted partial nephrectomy. J Robot Surg Tsukino K, Kobayashi S, Koura M, Takamatsu D, Nagakawa S, Tsukahara S, Tanegashima T, Matsumoto T, Shiota M, Oki E, Eto M. PMID: 42671671 [PubMed - indexed for MEDLINE]
	Pelvic floor muscle training for erectile function in men undergoing radical prostatectomy: a systematic review of randomized controlled trials. World J Urol Akdagcik Z, Aybal HÇ, Karaaslan M, Guven S, Tunc L, Yilmaz M. PMID: 42671634 [PubMed - indexed for MEDLINE]
	Black Race Predicts Poor Compliance and Higher Prostate Cancer Risk in a Multinational Repeat Biopsy Cohort: Secondary Analysis From the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Clinical Trial. Prostate Freedland AR, Moriera DM, Gong J, Freedland SJ. PMID: 42671204 [PubMed - as supplied by publisher]
	Long-Term Oncologic Outcomes of Neoadjuvant Tumor-Directed Immunotherapy (PROSTVAC) Before Radical Prostatectomy for Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Trial. Prostate Millan B, Kenigsberg AP, Hesswani C, Koller CR, Parikh SH, Blake Z, Fu H, Blachman-Braun R, Michael P, Gurram S, Turkbey B, Parnes H, Karzai F, Donahue RN, Schlom J, Gulley J, Pinto PA. PMID: 42671172 [PubMed - as supplied by publisher]
	Comparative Prognostic Impact of Two-Dimensional and Three-Dimensional Computed Tomography-Based Sarcopenia Indices in Metastatic Castration-Sensitive Prostate Cancer. Int J Urol Hori T, Iwamoto H, Inaba T, Nakagawa R, Kamijima T, Kano H, Makino T, Naito R, Kadomoto S, Yaegashi H, Shigehara K, Nohara T, Izumi K, Mizokami A. PMID: 42670789 [PubMed - indexed for MEDLINE]
	Comparative analysis of surgical outcomes: open versus robot-assisted radical prostatectomy. Scand J Urol Olsen RG, Brasso K, Røder A, Konge L, Bjerrum F, Stroomberg HV. PMID: 42670671 [PubMed - indexed for MEDLINE]
	Proton Therapy for Muscle-Invasive Bladder Cancer: Outcomes from the Multicenter Proton Collaborative Group PCG 001-09 Registry Trial. Cureus Oska C, Mehta KJ, Simone CB 2nd, Hsieh K, Garg MK, Tang J, Chhabra AM, Choi JI, Chang JH, Thukral AD Jr, Durci M, Nichols EM, Grover R, Gray J, Yacoub I. PMID: 42670565 [PubMed]
	Salvage Re-transurethral Resection of Prostate as a Diagnostic and Therapeutic Bridge in Treatment-Emergent Neuroendocrine Prostate Cancer: A Multimodal Management Paradigm. Cureus Kandhan L L, Korrapati VR, Yedulla Reddy R, Palaniyandi V, Sekar H, Krishnamoorthy S. PMID: 42670457 [PubMed]
	Chronic Kidney Disease in Children Within Five Years After Ifosfamide Chemotherapy for Childhood Cancer: A Dutch Pediatric Oncology Cohort Study. Cancer Med Pitlo L, Wens FSPL, Raymakers-Janssen PAMA, Haveman LM, Merks JHM, van Grotel M, Janssens GO, Fiocco M, van den Heuvel-Eibrink MM, van den Berg G. PMID: 42670233 [PubMed - indexed for MEDLINE]
	Editorial Comment to Validation of the NCCN Subclassification for Intermediate-Risk Prostate Cancer in a Japanese Radical Prostatectomy Cohort: Results From the MICAN Study. Int J Urol Kobayashi S. PMID: 42669948 [PubMed - in process]
	GSTM4 Suppresses Prostate Cancer Progression by Targeting TRIM27-mediated ACLY Ubiquitination and Lipid Metabolism. Adv Sci (Weinh) Xiong KP, Liu F, Wang W, Wang G, Qian KY, Tu S, Chen SM, Xu HM, Zhang SS, Li Y, Wang XH, Weng H. PMID: 42669779 [PubMed - as supplied by publisher]
	Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral. JACC CardioOncol Cano Garcia C, Pinthus J, Avezum A, Devereaux PJ, Klotz L, Higano C, Fradet V, Selvanayagam J, Guha A, Hajjar L, Lopez-Lopez JP, Xavier D, Ng K, Rangarajan S, Karampatos S, Agapay S, Mian R, Balasubramanian K, Cirne F, Huynh M, Davis MK, Hamilton RJ, Gopaul D, Mukherjee SD, Farooqi M, Benz AP, Richard R, Koo CYC, Leong DP, RADICAL PC Investigators. PMID: 42669076 [PubMed - as supplied by publisher]
	Prognostic significance of systemic immunoinflammatory biomarkers and pathological features in clear cell renal cell carcinoma: a multicenter study. Ann Med Yu Z, Yang J, Lv X, Zhang J, Chen D. PMID: 42669053 [PubMed - indexed for MEDLINE]
	Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial. JAMA Intern Med Leong DP, Higano C, Cano Garcia C, Fradet V, Siemens DR, Niazi T, Shayegan B, Guha A, Cirne F, Selvanayagam JB, Violette PD, Valle FH, Lavallée LT, Duceppe E, Anderson P, Xavier D, Lopez-Lopez JP, Villareal Trujillo N, Galapo Kann A, Piccoli RK, Mourtzakis M, Sarid D, Narasimha S, Luke PPW, Hajjar LA, Lukka H, Klotz L, Balasubramanian K, Mian R, Agapay S, Rangarajan S, Karampatos S, Ng KKH, Avezum A, Devereaux PJ, Pinthus JH, RADICAL PC Investigators. PMID: 42669035 [PubMed - as supplied by publisher]
	Clinico-genomic risk stratification for biomarker-enriched trial design in poor-prognosis metastatic castrate-resistant prostate cancer (mCRPC). J Liq Biopsy Kohli M, Wang L, Tan AC, Fadlullah MZ, Shankar A, Mandrekar SJ, Haaland B. PMID: 42668516 [PubMed]
	Comparative assessment of METastasis Reporting and Data System for Prostate Cancer versus Prostate Cancer Clinical Trials Working Group 3 Criteria in assessing treatment response in patients with metastatic castration-resistant prostate cancer. Eur Urol Open Sci Russo L, Longoria O, Bottazzi S, Porta N, Biscombe K, Withey SJ, Avesani G, Abramovicz K, Blackledge MD, D'Erme L, Russell-Rose K, Taha T, Sharp A, Paschalis A, Sala E, Koh DM, de Bono J, Tunariu N. PMID: 42668444 [PubMed]
	Prospective validation of a urine-based proteomics test for predicting clinically significant prostate cancer in biopsy-naÃ¯ve patients. Br J Cancer Morillo AC, Jobre KN, Lendinez Cano G, Blanca-Pedregosa A, Lopez Ruiz D, Parada J, Heidegger I, Culig Z, Lopez-Beltran A, Carrasco-Valiente J, Mischak H, Medina RA, Campos Hernandez JP, Frantzi M, Gómez Gómez E. PMID: 42668309 [PubMed - as supplied by publisher]
	Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial. Eur Urol Focus Zuur LG, de Barros HA, Ottens VA, Berrens AC, van Oosterom MN, Donswijk ML, Hendrikx JJMA, van Leeuwen FWB, van der Poel HG, van Leeuwen PJ. PMID: 42668258 [PubMed - as supplied by publisher]
	Emerging frontiers and challenges of artificial intelligence in PSMA-PET imaging: pioneering a new chapter in prostate cancer care. Jpn J Radiol Wang Y, Cheng C, Huang B, Zuo C. PMID: 42667563 [PubMed - as supplied by publisher]
	Expected costs and benefits of genetic counselling and germline genetic testing in metastatic prostate cancer. Hum Genet Vlaming M, Kiemeney LALM, Koole W, van Oort IM, Bleiker EMA, Ausems MGEM, Frederix GWJ. PMID: 42667419 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 181107

Seite 1 von 9056

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung